PNU-177864 (hydrochloride)
PNU-177864 is a potent, selective, orally active dopamine D3 receptor antagonist. PNU-177864 induces phospholipid metabolism in vivo and has anti-schizophrenia activity[1][2][3].
Product Specifications
CAS Number
1783978-03-9
UNSPSC
12352005
Target
CCR; Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pnu-177864-hydrochloride.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(OC(F)(F)F)C=C1)(NC2=CC=C(CCNCCC)C=C2)=O.[H]Cl
Molecular Formula
C18H22ClF3N2O3S
Molecular Weight
438.89
References & Citations
[1]Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32 (3) :326-32.|[2]Vonderfecht SL, et al. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol. 2004 May-Jun;32 (3) :318-25.|[3]Liana Basova , et al. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. PLoS One.2018 Jun 26;13 (6) :e0199861.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
D3 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A02077-1-carrier-free 100 µg/Vial
Anti-Sp7/Osterix Antibody Picoband®, Carrier-free
Sign In for Pricing
View Details 
